主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRDL
#5403
Cardiol Therapeutics Inc. Class A Common Shares
1.0
2
-0.97%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.97%
每月变动
+4.08%
6个月变化
-8.93%
年变化
-13.56%
前一天收盘价
1.0
3
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
2
交易量
3
市场
股票
医疗保健
CRDL
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Key stats
Total common shares outstanding
64.04 M
65.35 M
82.61 M
—
Valuation ratios
Enterprise value
34.59 M
57.51 M
105.74 M
—
Price to earnings ratio
—
—
—
—
Price to sales ratio
—
—
—
—
Price to cash flow ratio
—
—
—
—
Price to book ratio
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
—
—
—
—
Return on equity %
—
—
—
—
Return on invested capital %
—
—
—
—
Gross margin %
—
—
—
—
Operating margin %
—
—
—
—
EBITDA margin %
—
—
—
—
Net margin %
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
—
—
—
—
Inventory turnover
—
—
—
—
Asset turnover
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
—
—
—
—
Net current asset value per share
—
—
—
—
Tangible book value per share
—
—
—
—
Working capital per share
—
—
—
—
Book value per share
—
—
—
—
新闻
Cardiol Therapeutics发布二期心肌炎研究结果
Cardiol Therapeutics publishes phase II myocarditis study results
Cardiol Therapeutics提交包销协议和权证契约
Cardiol Therapeutics files underwriting agreement and warrant indenture
Cardiol Therapeutics宣布1350万美元私募配售
Cardiol Therapeutics announces $13.5 million private placement
Cardiol Therapeutics宣布1350万美元包销融资
Cardiol Therapeutics announces $13.5 million bought deal financing
Cardiol Therapeutics在复发性心包炎试验中达到50%入组率
Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial
H.C. Wainwright重申Cardiol Therapeutics股票买入评级,目标价9美元
H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target